Checkpoint genes cause cell cycle arrest when DNA is damaged or DNA replication is blocked. Although a human homolog of Chk1 (hChk1) has recently been reported to be involved in the DNA damage checkpoint through phosphorylation of Cdc25A, B, and C, it is not known at which phase(s) of the cell cycle hChk1 functions and how hChk1 causes cell cycle arrest in response to DNA damage. In the present study, we demonstrate that in normal human ®broblasts (MJ90), hChk1 is expressed speci®cally at the S to M phase of the cell cycle at both the RNA and protein levels and that it is localized to the nucleus at this time. hChk1 activity, as determined by phosphorylation of Cdc25C, is readily detected at the S to M phase of the cell cycle, and DNA damage induced by UV or ionizing radiation does not enhance the expression of hChk1 or its activity. Furthermore, hChk1 exists in an active form at the S to M phase in ®broblasts derived from patients with ataxia telangiectasia (AT) which lack the functional AT mutated (ATM) gene product, suggesting that hChk1 expression is independent of functional ATM. Taken together with the ®ndings that phosphorylation of Cdc25C on serine 216 is increased at the S to M phase, it is suggested that at this particular phase of the cell cycle, even in the absence of DNA damage, hChk1 phosphorylates Cdc25C on serine 216, which is considered to be a prerequisite for the G2/M checkpoint. Thus, hChk1 may play an important role in keeping Cdc25C prepared for responding to DNA damage by phosphorylating its serine residue at 216 during the S to M phase.
Introduction
Maintaining the genome stability of a cell requires a complex network of checkpoint mechanisms, ensuring that damaged DNA is repaired, that DNA replication cannot be initiated until completion of the previous mitosis and that mitosis does not occur until DNA replication is completed (Carr, 1996; Elledge, 1996; Enoch et al., 1991; Hartwell and Weinert, 1989; Humphrey and Enoch, 1995; Li and Deshaies, 1993; Murray, 1992; Nurse, 1994) . After detection of speci®c DNA or DNA-protein structures, a signal(s) is transduced to eector molecules that implement checkpoint-dependent responses such as cell-cycle arrest.
Checkpoints have been investigated genetically in the budding yeast Saccharomyces cerevisiae and the ®ssion yeast Schizosaccharomyces pombe (Lyndall and Weinert, 1995; Stewart and Enoch, 1996; Elledge, 1996) . In both, several Rad-related proteins are thought to participate in the signaling as well as monitoring process that detects DNA damage or incomplete DNA replication (Al-Khodairy and Carr, 1992; Enoch et al., 1992; Rowley et al., 1992; AlKhodairy et al., 1994) . Of these, rad3, a yeast homolog of human ATM (ataxia telangiectasia mutated), appears to play a central role in both DNA damage and DNA replication checkpoints (Savitsky et al., 1995; Bentley et al., 1996; Cimprich et al., 1996) . Rad3 is a member of a subfamily of protein kinases which consists of large proteins with a lipid kinase-related domain at their carboxyl terminus, and it is considered a likely transducer of a DNA damage signal in yeast.
Radiosensitivity is a universal characteristic of the human genetic disorder ataxia-telangiectasia (AT). Hypersensitivity to ionizing radiation has been demonstrated in AT patients exposed to radiotherapy (Goto et al., 1967; Morgan et al., 1968; Cunlie et al., 1975; Mockinnon, 1987; Gatti et al., 1991) and in cultured cells derived from the patients (Taylor et al., 1975 ). It appears likely that this sensitivity is due to a defect in a DNA damage checkpoint rather than to an inability to repair radiation damaged DNA. A mutation in the ATM gene results in impaired activation of p53 following DNA damage (Kastan et al., 1992; Khanna and Lavin, 1993) , leading to a failure to induce the transcription of the cyclin-dependent kinase inhibitor p21 gene. These observations indicate that ATM and rad3 play similar roles in the DNA damage checkpoint, and provide evidence that the DNA damage checkpoint pathway is well conserved between yeast and mammals.
The ®ssion yeast protein kinase Chk1 (SpChk1) and 14-3-3 homologs, rad24 and rad25, appear to be speci®c for the DNA damage checkpoint (Al- Khodairy et al., 1994; Walworth et al., 1993; Furnari et al., 1997) . DNA damage causes phosphorylation of SpChk1, which is dependent on the function of several checkpoint rad gene products including rad3+, suggesting a model in which the DNA damage signal is transduced through the rad gene products to modify SpChk1 (Walworth and Bernards, 1996) . Recently, mammalian homologs of SpChk1 protein kinase have been identi®ed and reported to phosphorylate Cdc25A, B, and C, creating a binding site for 14-3-3 protein (Sanchez et al., 1997; Peng et al., 1997) . It has been proposed that hChk1 is activated in response to DNA damage at all phases of the cell cycle and that activated hChk1 phosphorylates Cdc25A, B, and C, thereby preventing activation of cyclin/Cdk complexes and cell cycle progression in mammalian cells as well as in yeast (Sanchez et al., 1997) . However, to elucidate the functions of hChk1 in the DNA damage checkpoint in mammalian cells, it appears necessary to determine at which phase(s) of the cell cycle hChk1 functions and how hChk1 regulates the DNA damage checkpoint pathway.
In the present study, we demonstrate that hChk1 protein and its activity are expressed speci®cally at the S to M phase of the cell cycle in both normal and AT 7/7 human ®broblasts (AT cells). In addition, the kinase activity is not altered in response to DNA damage induced by UV or ionizing radiation in normal or AT cells. Together with the observations that phosphorylation of Cdc25C on serine 216 is increased at the S to M phase, but not altered in response to DNA damage in normal or AT cells, it is suggested that hChk1 protein kinase plays a role in maintaining the phosphorylation of Cdc25C on serine 216 in the absence of DNA damage, which is indispensable for cell cycle arrest induced by the DNA damage checkpoint (Peng et al., 1997) .
Results

Cell cycle-dependent expression of human Chk1
Although cell cycle-dependent expression of Chk1 has not been observed in S. pombe, we ®rst asked whether this is also the case with human Chk1 (hChk1) to gain some insight on when hChk1 functions in mammalian cells. Normal human ®broblasts (MJ90) were synchronized at the G0 phase of the cell cycle by serum starvation for 72 h, and then stimulated with fresh medium containing 15% FBS. Flowcytometry showed that S phase started approximately 18 h after serum stimulation and that maximal cell division occurred at 24 ± 36 h (data not shown). As shown in Figure 1a , Northern blot analysis with hChk1 cDNA probe revealed that two species of hChk1 transcripts at approximately 2.0 and 4.0 Kb were weakly detected in serum-starved, quiescent cells (time 0). The steady-state levels of hChk1 mRNA dramatically increased as cells approached the G1/S transition (at 18 h) and remained elevated until 24 h ( Figure 1a ). Although cells rapidly lost synchrony in the second cycle, hChk1 mRNA levels seemed to decline during the next G1 phase (36 ± 48 h).
To examine whether the level of hChk1 protein also changes in a cell cycle-dependent fashion, we raised antisera against full-length hChk1 protein expressed in insect cells, and extracts from synchronized cells were analysed by Western blotting using anity puri®ed anti-hChk1 antibody. As shown in Figure 1b (left panel), the antibody detected a predominant band at Figure 1 Cell cycle-dependent expression of hChk1 mRNA and protein in normal human ®broblasts. Quiescent normal human ®broblasts (MJ90) were stimulated with serum and were harvested at the indicated times. (a) mRNA isolated from synchronized MJ90 cells (2 mg each) was subjected to electrophoresis on a 1% formaldehyde-agarose gel, and Northern blotting was performed as described in Materials and methods using hChk1 cDNA as a probe. The position of two species of hChk1 mRNA is shown. (b) Synchronized MJ90 cells were harvested at the indicated times in IP-kinase buer, and the cell lysates (100 mg/lane) were separated by SDS ± PAGE and transferred onto a nitrocellulose membrane. hChk1 protein was detected by Western blotting using anti-hChk1 antibody at 1 : 1000 dilution (left panel) or anti-hChk1 antibody pre-absorbed with GST-hChk1 protein (right panel). AS denotes asynchronous cells hChk1 functions at S to M phase Y Kaneko et al 52 kDa in the lysates of MJ90 cells, which completely disappeared after pre-absorption of the antisera with GST-fused hChk1 protein expressed in E. coli ( Figure  1b , right panel). Taken together with the molecular mass predicted from the deduced amino acid sequence and the results that anti-hChk1 antibody recognized only one spot in two-dimensional electrophoresis (data not shown), the 52 KDa band seems to represent the endogenous protein product of the hChk1 gene. In agreement with the results of the Northern analysis, hChk1 protein was hardly detectable in quiescent MJ90 cells (time 0), but markedly increased at and after the G1/S boundary (at 18 ± 24 h) and declined substantially during the next G1 phase (48 h).
Identi®cation of an antibody that immunoprecipitates hChk1 in a kinase active form
In an attempt to see if the endogenous hChk1 product has kinase activity, we ®rst analysed the enzymatic properties of hChk1HA protein expressed in insect cells. As shown in Figure 2a , hChk1HA eectively phosphorylated both the GST-fused Cdc25C fragment (amino acids 195 ± 256) as well as the full-length Cdc25C protein (data not shown), whereas a mutant hChk1 (K38M) did not. In view of the fact that the GST-S216A fragment of Cdc25C (amino acids 195 ± 256), in which Ser216 was replaced with alanine, was not eectively phosphorylated by immunoprecipitated hChk1 protein (Figure 2c ), it was suggested that hChk1 phosphorylates Cdc25C on serine 216. Interestingly, wild-type hChk1HA, but not the K38M mutant, appeared to cause autophosphorylation ( Figure 2a ). To determine the autophosphorylation site(s) in the hChk1 protein, we made GST-fused truncated mutants of hChk1 in E. coli, and tested whether they could be phosphorylated by hChk1HA. As shown in Figure 2b , only GST-hChk1 261 ± 340 was autophosphorylated by puri®ed hChk1HA, suggesting that the autophosphorylation site(s) lies between amino acids 261 and 340 of the hChk1 protein.
We next determined whether our antibody against hChk1 protein immunoprecipitates hChk1 protein in a kinase active form. As shown in Figure 2c , anti-HA antibody immunoprecipitated signi®cant activity of hChk1HA, as determined by phosphorylation of the Cdc25C fragment, whereas immunoprecipitates with normal rabbit serum gave only a background activity. The kinase activity was fully precipitated from the latter by adding 2 mg of anti-HA antibody (data not shown). Importantly, our polyclonal antibody against hChk1 immunoprecipitated kinase activity as eectively as the anti-HA antibody, whereas almost no kinase activity was recovered from the insect lysates expressing inactive hChk1 (K38M) using either the anti-HA or anti-hChk1 antibody ( Figure 2c ). Taken together, it is concluded that anti-hChk1 antibody can immunoprecipitate hChk1 protein in a kinase active form.
hChk1 is active at S to M phase of the cell cycle and phosphorylates Cdc25C on serine 216 in vivo In order to examine whether hChk1 activity changes during cell cycle progression in normal human cells, endogenous hChk1 protein was immunoprecipitated with anti-hChk1 antibody from MJ90 cells at various intervals after serum stimulation, and the precipitates were assayed for kinase activity using the GST-Cdc25C fragment (amino acids 195 ± 256) as a substrate. As shown in Figure 3 , hChk1 activity was barely detectable during G0 and G1, but increased dramatically toward the onset of S phase (18 h), peaked at 24 h after serum stimulation, and decreased thereafter. The GST-S216A fragment of Cdc25C (amino acids 195 ± 256) was not phosphorylated at all by immuno- Figure 2 Anti-hChk1 antibody immunoprecipitates active hChk1 kinase. (a) HA-tagged wild type hChk1 (WT) and mutant hChk1 (K38M) expressed in Sf9 cells were immunoprecipitated with anti-HA antibody as described in Materials and methods. The immunoprecipitates were assayed for kinase activity using GSTCdc25C fragment as a substrate. The phosphorylated proteins were separated by SDS ± PAGE and detected by autoradiography. The positions of hChk1 and GST-Cdc25C are indicated by arrows on the right side of the ®gure. Molecular weight markers are shown on the left side. (b) Various GST-hChk1 fragments (1 mg each) covering the whole region of hChk1 protein were used as substrates for in vitro kinase assay of hChk1 expressed in Sf9 cells as described in Materials and methods. The phosphorylated proteins were separated by SDS ± PAGE and detected by autoradiography. (c) Anti-hChk1 antibody immunoprecipitates active hChk1 as eectively as anti-HA antibody. Wild type (WT) or mutant (K38M) hChk1-HA protein expressed in Sf9 cells was immunoprecipitated with 2 ml of normal rabbit serum (NRS), anti-HA or anti-hChk1 antibody. The immunoprecipitates were assayed for kinase activity using GST-Cdc25C fragment (amino acids 195 ± 256) and GST-S216A (aa 195 ± 256) fragment as a substrate hChk1 functions at S to M phase Y Kaneko et al precipitated hChk1 protein, which further supports the concept that Ser216 in Cdc25C is the phosphorylation site of hChk1. Taken together with the cell cycledependent alterations in hChk1 protein levels ( Figure  1b) , it is conceivable that the upregulation of hChk1 activity at the onset of S phase is due to an increase in the amount of the protein. It should be noted that the speci®c activity of endogenous hChk1 at S phase was comparable to that expressed in Sf9 cells when GSTCdc25C was used as a substrate (data not shown).
Although the expression of hChk1 protein and mRNA appeared) to decrease during the next G1 phase (Figure 1 ), this needed to be clari®ed since synchronization was poor at the later time points. To address this issue, HeLa cells were synchronized by release from a sequential thymidine/aphidicolin block. Under these conditions, most cells entered S phase within 1 h, reached G2 phase at 9 h, and entered the next G1 phase at 13 h (data not shown). As shown in Figure 4a , hChk1 protein was barely detectable at the G1/S boundary (0 h) but started to be detected at the onset of S phase (2 h after release). The amount of hChk1 protein gradually increased as cells reached the G2 phase (6 ± 8 h after release), and then decreased again as cells entered the next G1 phase (12 h).
In contrast, the total amount of Cdc25C protein, including unphosphorylated and phosphorylated forms, remained almost constant during the whole experimental period (Figure 4b ). Ectopic expression of the S216A mutant of Cdc25C in these cells revealed that the upper band represents a form phosphorylated on Ser216 (data not shown). Interestingly, the proportion of phosphorylated Cdc25C was low at the G1/S boundary (0 ± 2 h), gradually increased as cells reached the G2 phase (8 h), and then decreased again at the next G1 phase (Figure 4b ), which correlated well with the expression of hChk1 protein (Figure 4a ). Taken together, these results are consistent with the concept that hChk1 phosphorylates Cdc25C on serine 216 during the S to M phase of the cell cycle, even in the absence of DNA damage.
hChk1 protein is localized to the nucleus during S to M phase
We next determined the subcellular localization of hChk1 protein. As shown in Figure 5a and b, indirect immuno¯uorescence revealed that almost no signal was detected in quiescent (0 h) and mid G1 phase cells (12 h after serum stimulation). Nuclear signals were detected in late G1 to S phase cells (Figure 5c , 24 h after serum stimulation) and in mitotic cells (Figure 5d and e). These observations are consistent with the results of the Western analysis (Figure 1b) , and indicate that hChk1 is localized to the nucleus at the S to M phase of the cell cycle. In addition, nuclear localization of hChk1 was not aected by DNA damage (data not shown). Figure 3 Cell cycle-dependent changes in endogenous hChk1 kinase activity in normal human ®broblasts. Quiescent MJ90 cells were stimulated by adding serum as described in Materials and methods, and were harvested at the indicated times. The cell lysates (1 mg each) were immunoprecipitated with anti-hChk1 antibody, and the immunoprecipitates were assayed for kinase activity using GST-Cdc25C fragment (aa 195 ± 256) and GST-S216A fragment (aa 195 ± 256) as a substrate. NRS and AS refer to normal rabbit serum and asynchronous cells, respectively In an attempt to examine whether hChk1 activity changes in response to DNA damage, we ®rst determined cyclin B/Cdc2 activity after UV or ionizing irradiation to be sure that our experimental conditions are suitable for analysis of the DNA damage checkpoint. In this experiment, we stimulated quiescent MJ90 cells by adding serum and synchronized the cells at S phase 24 h after stimulation. As shown in Figure 6 , in control cells without irradiation, cyclin Bassociated kinase activity started to increase at 120 min and reached a maximum at 240 min. In contrast, cyclin B/Cdc2 activity decreased after treatment with UV or ionizing radiation, and was not activated at all despite the fact that the levels of both cyclin B and Cdc2 proteins were constant after irradiation (data not shown). These results indicate that under our experimental conditions DNA damage induced by UV or ionizing radiation arrests the cell cycle by inhibiting the activation of cyclin B/Cdc2.
DNA damage does not aect hChk1 activity
In order to determine whether hChk1 activity is enhanced in response to DNA damage in normal human ®broblasts, we measured the activity of hChk1 in the lysates of cells treated with ionizing radiation at S to G2 phase. As shown in Figure 7a , no apparent change in the activity of hChk1 was observed following irradiation during the experimental period (0 ± 300 min). Neither methyl methanesulfonate (MMS), which is known to induce DNA damage, nor hydroxyurea, which is known to induce S phase arrest, aected the activity of hChk1 (data not shown). These results indicate that hChk1 activity is not enhanced in response to DNA damage or the arrest of DNA replication in normal ®broblasts. Although a recent report showed that the band corresponding to hChk1 is shifted upward following DNA damage (Sanchez et al., 1997) , no signi®cant modi®cation of hChk1 protein in response to DNA damage induced by treatment with UV, ionizing irradiation, or MMS was observed by Western blotting or by two-dimensional electrophoresis under our experimental conditions (data not shown).
We also determined whether phosphorylation of Cdc25C on Ser216 was regulated in response to DNA damage, by analysing the mobility of endogenous Cdc25C protein after X-ray irradiation. As shown in Figure 7b , most of the Cdc25C in normal human ®broblasts was phosphorylated on Ser216 at S phase (time 0, 24 h after stimulation). Although the total amount of Cdc25C protein increased 60 ± 180 min after X-ray irradiation, the proportion of the two forms did not appear to change signi®cantly (Figure 7b ).
hChk1 protein and its activity in AT cells
In S. pombe, Chk1 is thought to function downstream of the rad3 product, a gene with sequence similarity to the ATM gene found to be mutated in patients with ataxia telangiectasia (Savitsky et al., 1995; Bentley et al., 1996; Cimprich et al., 1996) . To see if the expression of hChk1 is regulated by functional ATM in human cells, we examined the expression and activity of hChk1 in ®broblasts derived from a patient with ataxia telangiectasia. Northern ( Figure 8a ) and Western (Figure 8b ) blot analyses revealed that the expression of both hChk1 mRNA and protein changed in a cell cycledependent fashion in AT cells, which was similar to that of normal cells (Figure 1 ). hChk1 kinase activity was also readily detectable in AT cells and regulated in a cell cycle-dependent manner (Figure 8c ). These results suggest that hChk1 expression and activity are independent of the function of the ATM gene product.
Finally, we determined whether the activity of hChk1 would be aected in AT cells in response to DNA damage. As shown in Figure 8d , no apparent change in hChk1 activity was observed at S to G2 phase in AT cells after treatment with UV or ionizing radiation, indicating that DNA damage does not aect hChk1 kinase activity in AT cells, either. Again, no signi®cant mobility shift of the hChk1 protein was observed in AT cells on Western analysis (data not shown). Figure 6 Inhibition of cyclin B/Cdc2 activation by UV or X-ray irradiation. Synchronized MJ90 cells at S phase were irradiated with either 0.15 j/cm 2 of UV or 10 Gy of X-ray. Cells were harvested at the indicated times (min), and cyclin B/Cdc2 complexes were immunoprecipitated using anti-cyclin B antibody and were assayed for kinase activity using histone H1 as a substrate.`None' represents a control experiment without irradiation Figure 7 Ionizing radiation does not cause hChk1 activation or mobility shift of Cdc25C. Synchronized MJ90 cells at S phase were irradiated with 10 Gy of X-ray. Cells were harvested at the indicated times (min), and the cell lysates (100 mg protein) were assayed for hChk1 kinase activity using GST-Cdc25C fragment (amino acids 195 ± 256) and GST-S216A (aa 195 ± 256) fragment as a substrate (a) or analysed by Western blotting using antiCdc25C antibody at 1 : 1000 dilution (b). The positions of phosphorylated and unphosphorylated forms of Cdc25C are indicated on the right side (b) hChk1 functions at S to M phase Y Kaneko et al
Discussion
Cell cycle-dependent expression and nuclear localization of hChk1
Previous studies suggested that in S. pombe, Chk1 protein kinase acts as a signal transducer for cell cycle arrest in response to DNA damage (Walworth et al., 1993; Walworth and Bernards, 1996; Furnari et al., 1997) . From the observations that checkpoint arrest in the G2 phase requries functional Chk1 and that overexpression of Chk1 protein induces G2 arrest in S. pombe, Chk1 appears to act at the G2 phase of the cell cycle. A human homolog of SpChk1, hChk1, has recently been identi®ed and reported to phosphorylate not only Cdc25B and C but also Cdc25A, which is thought to act at the G1 phase, suggesting that hChk1 may also function at G1 phase (Sanchez et al., 1997; Peng et al., 1997) .
To ask at which phase(s) of the cell cycle hChk functions in human cells, we ®rst sought to determine if the expression of hChk1 changes during the normal cell cycle. Unexpectedly, we found that hChk1 is expressed in a cell cycle-dependent manner at both the mRNA and protein levels, with almost no expression at G0 to late G1 and high expression at the S to M phase (Figure 1 ). These data make it unlikely that hChk1 functions at the G1 phase in mammalian cells, and raises the possibility that another pathway(s) exists that transduces a signal in response to DNA damage at G1 phase.
The results of immunocytochemistry con®rmed the cell cycle-dependent expression of hChk1 protein, providing evidence that hChk1 protein is localized to the nucleus in a punctuate pattern at S to M phase, but not in G0 to early G1 phase cells ( Figure 5 ).
Endogenous hChk1 is active in the absence of DNA damage
Although it has been proposed that DNA damage activates SpChk1 and that activated SpChk1 transduces a signal to downstream eectors such as Cdc25 in ®ssion yeast (Weinert, 1997; Furnari et al., 1997) , it remains to be determined whether this is also the case with hChk1. To address this issue, we determined whether endogenous hChk1 exists as an active or inactive kinase during cell cycle progression. Using an antibody against hChk1 which immunoprecipitates hChk1 protein in an active form (Figure 2) , we demonstrated that hChk1 activity is present in a cell cycle-dependent manner, whose pattern correlates well with the expression of hChk1 protein (Figure 1b) . The timing of Cdc25C phosphorylation on serine 216 coincided with the expression of hChk1 protein (Figure 4a and b) , suggesting that the phosphorylation is mediated at least in part through hChk1 in vivo.
Although overexpression of SpChk1 arrests the cell cycle at G2 in ®ssion yeast, overexpression of hChk1 did not aect the cell cycle in mammalian cells (data not shown). These observations support our concept that unlike in yeast, in mammalian cells hChk1 exists as an active kinase in the absence of DNA damage and that the phosphorylation of Cdc25C on serine 216 is not sucient for cell cycle arrest.
DNA damage does not enhance hChk1 activity
To determine whether DNA damage enhances Chk1 activity in mammals, we measured hChk1 activity in extracts of cells treated with UV or ionizing radiation at S to G2 phase. The results indicated that hChk1 activity is not enhanced in response to DNA damage in normal human ®broblasts. Furthermore, under our experimental conditions, no apparent modi®cation of hChk1 protein was observed in response to DNA Figure 8 The expression and activity of hChk1 in ATM-de®cient (AT7/7) human ®broblasts. AT cells were rendered quiescent by serum starvation and then stimulated by adding serum. The synchronized cells were harvested at the indicated times (hours or minutes). (a) mRNA isolated from synchronized AT cells (2 mg each) was electrophoresed on a 1% formaldehyde-agarose gel, and Northern blotting was performed as described in Materials and methods using hChk1 cDNA as a probe. The position of two species of hChk1 mRNA is shown. (b) The cell lysates (100 mg protein) were separated by SDS ± PAGE and transferred onto a nitrocellulose membrane. hChk1 protein was detected by Western blotting using anti-hChk1 antibody at 1 : 1000 dilution. (c) The cell lysates (1 mg each) were immunoprecipitated with anti-hChk1 antibody, and the immunoprecipitates were assayed for kinase activity using GST-Cdc25C fragment (amino acids 195 ± 256) and GST-S216A fragment (aa 195 ± 256) as a substrate. NRS indicates normal rabbit serum. (d) Treatment with UV or ionizing radiation does not enhance hChk1 activity in AT cells. AT cells synchronized at S phase were irradiated with either UV (0.15 J/ cm 2 ) or X-ray (10 Gy), and were harvested at the indicated times (min). The cell lysates (1 mg each) were immunoprecipiated with anti-hChk antibody, and the immunoprecipitates were assayed for hChk1 kinase activity using GST-Cdc25C fragment and GST-S216A fragment as a substrate. The labeled proteins were separated on SDS ± PAGE and detected by autoradiography hChk1 functions at S to M phase Y Kaneko et al damage in normal human ®broblasts or in ®broblasts lacking functional ATM. These results contrasted with those of Sanchez et al. (1997) who showed a minor reduction in the mobility of hChk1 protein on SDS ± PAGE in HeLa cells (Sanchez et al., 1997) . Although this change in the mobility was con®rmed by twodimensional gel analysis, it is not known whether the mobility shift was caused by phosphorylation of hChk1 protein following DNA damage. There is an alternative explanation for the modification of hChk1 in response to DNA damage being cell type-speci®c. Interestingly, it has recently been reported that loss of SpCds1 protein kinase results in abnormal activation and modi®cation of SpChk1 protein in S. pombe (Lindsay et al., 1998) . It was suggested that SpCds1 acts in a branch of the checkpoint response separate from SpChk1 and that SpCds1 is required for the response to DNA damage (Boddy et al., 1998) . Thus, loss of hCds1 function may enhance hChk1 signals in HeLa cells like in ®ssion yeasts.
The phosphorylation of Cdc25C on serine 216 has been reported to be important for its binding to 14-3-3 proteins (Peng et al., 1997) . Although phosphorylation of Cdc25C on serine 216 does not appear to aect its phosphatase activity, 14-3-3 binding may negatively regulate Cdc25C activity. Hermeking et al. (1997) reported that 14-3-3s is strongly induced through p53 function in response to DNA damage (Hermeking et al., 1997) . Since the ®ssion yeast 14-3-3 homologs, rad24 and rad25, function downstream of SpChk1, it is conceivable that both phosphorylation of Cdc25C on serine 216 and the induction of 14-3-3 protein are required for the inactivation of Cdc25C, leading to G2/M arrest.
hChk1 is active in AT cells
In S. pombe, Chk1 has been reported to function downstream of rad3, a ®ssion yeast homolog of ATM (Walworth and Bernards, 1996) . Although a previous study suggested that the expression of hChk1 protein is dependent upon a functional ATM gene product (Flaggs et al., 1997) , our data show that hChk1 is present in a cell cycle-dependent manner in AT cells both at the mRNA and protein levels, like in normal cells, suggesting that hChk1 expression is independent of the ATM gene product at least in ®broblasts.
Importantly, our results indicate that hChk1 exists in an active form in AT cells and that neither UV nor ionizing radiation causes changes in the kinase activity or a mobility shift of the protein. In addition, the phosphorylated form of Cdc25C on serine 216 was predominant at S to G2/M phase in AT cells as well as in normal cells, and the proportion of phosphorylated Cdc25C did not increase in response to DNA damage. These results make it unlikely that ATM directly regulates hChk1 activity, although there still remains the possibility that ATM and/or ATR regulate hChk1 function through an as yet unidenti®ed mechanism in response to DNA damage.
In the present study, we have provided evidence for cell cycle-dependent expression of hChk1 protein and its existence in an active form in the absence of DNA damage. Our observations suggest that hChk1 maintains phosphorylation of Cdc25C on serine 216, which is necessary for 14-3-3 binding, but argue against the possibility that hChk1 transduces a checkpoint signal. Taken together with the ®ndings that overexpression of 14-3-3 protein arrests the cell cycle at the G2 phase in cells (Hermeking et al., 1997), 14-3-3 proteins may be a rate-limiting factor for the DNA damage checkpoint in mammals. Although SpChk1 protein is phosphorylated in response to DNA damage in yeast, it is not clear how the phosphorylation of SpChk1 aects its activity and how SpChk1 functions in the DNA damage checkpoint. SpChk1 may also act in maintaining phosphorylation of Cdc25, which is necessary for its binding to rad24 and rad25, the yeast homologs of 14-3-3 proteins. Recently, another kinase (C-TAK1) has been reported to phosphorylate Cdc25C on serine 216 (Peng et al., 1998) , but it remains to be determined whether this kinase is involved in the phosphorylation of Cdc25C on serine 216 during cell cycle progression and how it functions in the DNA damage checkpoint. At present there is no direct evidence for the involvement of hChk1 in DNA damage and/or replication checkpoints in mammalian cells. To answer this critical question, knockout experiments of hChk1 may be necessary.
Materials and methods
Cell culture and synchronization
Human diploid ®broblasts (MJ90) and HeLa cells were cultured in Dulbecco's modi®ed Eagle medium (DMEM, Gibco BRL) supplemented with 10% heat-inactivated FBS (Gibco BRL) as described previously (Nakanishi et al., 1995) . Human diploid ®broblasts derived from a patient with ataxiatelangiectasia (AT2KY, referred as AT cells) were cultured in RPMI 1640 medium (Gibco BRL) supplemented with 20% heat-inactivated FBS. Quiescent cells (G0) were synchronized by serum depletion (cultured in the media containing 0.5% FBS) for at least 3 days. HeLa cells were synchronized at the G1/S boundary by sequential thymidine/aphidicolin block (Watanabe et al., 1995) .
Preparation of recombinant hChk1 protein in Sf9 cells
Baculoviruses expressing hChk1HA and hChk1myc/6xHis were generated by PCR with a common 5' primer (GGGAATTCGGTGGAGTCATGGCAGTGCCC) and 3' primers (GGGGCGGCCGCCTGTGGCAGGAAGCCA-AACCTT) for HA tag or (GGCTCGAGTGTGGCAGGA-AGCCAAACCTT) for myc/6xHis tag, respectively, using cDNA derived from MJ90 cells as a template. The PCR products were digested with EcoRI/NotI for HA tag or EcoRI/XhoI for myc/6xHis tag, and were ligated into pcDNA3HA or pcDNA3.1/Myc-HisA, respectively. The EcoRI/PmeI fragment from pcDNA3.1/myc-His hChk1 and the EcoRI/XhoI fragment (the XhoI site was treated with Klenow fragment) from pcDNA3HAhChk1 were subcloned into pVL1392, which was cut with EcoRI/SmaI. One mg pVL1392hChk1myc/6xHis or pVL1392hChk1HA was cotransfected with 2.5 mg linearized baculovirus DNA (BaculoGold: Pharmingen) into Sf9 cells.
Preparation of GST-fused hChk1 protein in E. coli pGEX-hChk1 was generated by ligation of the EcoRI/XhoI fragment of hChk1 cDNA into pGEX 5X-1. pGEX-hChk1 fragments 1 ± 100, 101 ± 180, 181 ± 260, 261 ± 340, 331 ± 400, and 401 ± 476 were generated by PCR with the following sets of primers; a common 5' primer and GGGCTCGAGTCA-TATGTCTGGCTCTATTCTGTC for 1 ± 100; GGGGAAhChk1 functions at S to M phase Y Kaneko et al TTCGGCATGCCTGAACCAGATGCT and GGGCTCGA-GT CA CTTCAGA ACT TCTGG AG CA AG for 101 ± 180; G GG GAA TT CA GAA GAG A AT TTC ATGC AGAA and GGGCTCGAGTCATTTGATGTCTGGAATGGTAAT for 181 ± 260; GG GG AA TT CA AA GA TA GA TG GT AC AA-CA AA and GG GC TC GA GT CA TT GT AC CA AT TT AT-CAATGTA for 261 ± 340; GGGGAATTCCCCCGCAC-AGGTCTTTCCTTA and GGGCTCGAGTCACAACTTC-TCACAAGTCTCTTT for 331 ± 400; GGGGAATTCGGC-TATCAATGGAAGAAAAGT and GGCTCGAGTGTGG-CAGGAAGCCAAACCTT for 401 ± 476 using pcDNA3-hChk1myc/66His as a template.
The pGEX-Cdc25C fragment (195 ± 256) was generated by PCR with a 5' primer (CGCGCGGATCCCCATGGAG-TTTTCCCTGAAA) and a 3' primer (CCAGTGAATT-CCCTCAGCCCTTCCTGAGCTTTCC) using MJ90-derived cDNA as a template. The pGEX-S216A fragment (195 ± 256) was generated by PCR with a sense primer (TATCGCTCCCCGGCGATGCCA) and an antisense primer (AGTTCTCTGGCATCGCCGGGG) using pGEXCdc25C as a template. The PCR product was digested with BamHI and EcoRI, and was ligated into pGEX-3X. Overnight cultures of E. coli transformed with plasmids encoding the GST-fusion proteins were diluted tenfold with fresh medium and cultured for 2 h at 378C, followed by incubation with 0.1 mM IPGT (isopropyl-b-D-thiogalactopyranoside) for 2 h. Cells were harvested and lysed by sonication in NETN150 buer (20 mM Tris, pH 8.0, 150 mM NaCl, 1 mM EDTA, 0.5% NP-40, and a cocktail of protease inhibitors: 20 mg/ml soybean trypsin inhibitor, 2 mg/ml apoprotin, and 100 mg/ml phenylmethylsulfonyl¯uoride [PMSF]). Recombinant proteins were puri®ed on glutathione-sepharose beads (Pharmacia).
Preparation of anti-hChk1 antibody
hChk1myc/6xHis protein expressed in Sf9 was puri®ed on ProBond Resin (Invitrogen), and used to immunize rabbits. Sera were tested for reactivity against puri®ed hChk1myc/ 6xHis expressed in Sf9, GST-fused hChk1 expressed in E. coli, and asynchronized MJ90 cell extracts by Western blotting. Antisera were anity puri®ed on CNBr-activated sepharose 4B (Pharmacia) coupled with GST-fused hChk1 protein, and the concentration was adjusted to 0.15 mg/ml.
Northern blot analysis
Poly(A + ) mRNA was isolated using an mRNA puri®cation kit (Pharmacia), and subjected to electrophoresis on a 1% formaldehyde-agarose gel. Hybridization was carried out in 50% formamide at 428C for 24 h.
Western analysis and immunocytochemistry
For Western analysis, synchronized MJ90 cells and AT cells were lysed with IP kinase buer (50 mM HEPES, pH 8.0, 150 mM NaCl, 25 mM EGTA, 1 mM EDTA, 0.1% Tween 20, and 10% glycerol) containing a cocktail of protease inhibitors (20 mg/ml soybean trypsin inhibitor, 2 mg/ml aprotinin, 5 mg/ ml leupeptin, and 100 mg/ml PMSF) and phosphatase inhibitors (50 mM NaF, 0.1 mM Na 3 VO 4 ) and 5 mg/ml phosphatase substrate). The lysates (100 mg) were separated by SDS ± PAGE and analysed by Western blotting using antihChk1 antibody (1 : 1000) or anti-Cdc25C antibody (1 : 1000) (Santacruz). The signals were enhanced with chemiluminescence (Amersham).
For immunocytochemistry, MJ90 cells were ®xed with 4% paraformaldehyde and permeabilized with 0.2% Triton X-100. The permeabilized cells were incubated with anti-hChk1 antibody (1 : 100) and then with¯uorescein isothiocyanateconjugated anti-rabbit IgG (Immunotech) (1 : 100). The stained cells were detected with a conforcal microscopy (Olympus).
Kinase assay
Wild-type hChk1HA and its mutant (K38M) expressed in Sf9 were immunoprecipitated with anti-HA antibody (12CA5; Boehringer Mannheim). For measurement of kinase activity in MJ90 cells or AT cells, cell lysated were immunoprecipitated with anti-hChk1 antibody coupled to CNBr-activated sepharose 4B. The kinase activity was determined at 308C for 30 min in a 30 ml reaction mixture containing 50 mM HEPES, pH 8.0, 10 mM MgCl 2 , 2.5 mM EGTA, 1 mM DTT, 10 mM bglycerophosphate, 1 mM NaF, 0.1 mM Na 3 VO 4 , 0.1 mM PMSF, 10 mM ATP and 185 Kbq[g-32 P]ATP (222 TBq/ mmol; NEM). The GST-Cdc25C fragment, the GST-S216A fragment or the GST-hChk1 fragment was used as a substrate. The reaction products were separated on SDS ± PAGE, and phosphorylated proteins were detected by autoradiography.
